These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 3501795

  • 21. In vivo effects of recombinant IL-2. I. Isolation of circulating Leu-19+ lymphokine-activated killer effector cells from cancer patients receiving recombinant IL-2.
    McMannis JD, Fisher RI, Creekmore SP, Braun DP, Harris JE, Ellis TM.
    J Immunol; 1988 Feb 15; 140(4):1335-40. PubMed ID: 3257776
    [Abstract] [Full Text] [Related]

  • 22. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
    van de Griend RJ, Ronteltap CP, Gravekamp C, Monnikendam D, Bolhuis RL.
    J Immunol; 1986 Mar 01; 136(5):1700-7. PubMed ID: 3005399
    [Abstract] [Full Text] [Related]

  • 23. Cytolytic activity of murine IL-2-producing CD4+ and CD8+ T cell clones cycles in response to IL-2.
    McKisic MD, Lancki DW, Cronin DC, Fitch FW.
    J Immunol; 1993 Oct 15; 151(8):4055-66. PubMed ID: 8409385
    [Abstract] [Full Text] [Related]

  • 24. Toxicity and immunologic effects of continuous infusion of recombinant human interleukin-2 administered by selective hepatic perfusion in dogs.
    Da Pozzo LF, Hough KL, Holder WD.
    Surgery; 1992 Mar 15; 111(3):326-34. PubMed ID: 1542858
    [Abstract] [Full Text] [Related]

  • 25. Loxoribine (7-allyl-8-oxoguanosine) activates natural killer cells and primes cytolytic precursor cells for activation by IL-2.
    Pope BL, Chourmouzis E, Victorino L, MacIntyre JP, Capetola RJ, Lau CY.
    J Immunol; 1993 Sep 15; 151(6):3007-17. PubMed ID: 8376766
    [Abstract] [Full Text] [Related]

  • 26. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ, Tanimoto T, Kohno K, Ikeda M, Kurimoto M.
    Cancer Res; 1997 Oct 15; 57(20):4557-63. PubMed ID: 9377569
    [Abstract] [Full Text] [Related]

  • 27. Pretreatment of human peripheral blood lymphocytes with interleukin-2 or dexamethasone does not alter their response to Met-Enkephalin in a NK-cytotoxic assay.
    Martin-Kleiner I, Gabrilovac J.
    Immunopharmacol Immunotoxicol; 1996 Feb 15; 18(1):37-57. PubMed ID: 8683038
    [Abstract] [Full Text] [Related]

  • 28. Interleukin-2-induced decrease in the buoyant density of cytotoxic cells and its relationship with proliferation.
    Sarin A, Saxena RK.
    Nat Immun Cell Growth Regul; 1989 Feb 15; 8(5):279-89. PubMed ID: 2556638
    [Abstract] [Full Text] [Related]

  • 29. Repeated restraint stress impairs the antitumor T cell response through its suppressive effect on Th1-type CD4+ T cells.
    Li T, Harada M, Tamada K, Abe K, Nomoto K.
    Anticancer Res; 1997 Feb 15; 17(6D):4259-68. PubMed ID: 9494518
    [Abstract] [Full Text] [Related]

  • 30. Leukocyte Interleukin, Inj. (LI) augmentation of natural killer cells and cytolytic T-lymphocytes.
    Chirigos MA, Talor E, Sidwell RW, Burger RA, Warren RP.
    Immunopharmacol Immunotoxicol; 1995 May 15; 17(2):247-64. PubMed ID: 7650289
    [Abstract] [Full Text] [Related]

  • 31. [The in vitro antitumor effectiveness of murine lymphokine-activated killer (LAK) cells induced by recombinant IL-2].
    Okamoto Y, Shimizu K, Miyao Y, Ushio Y, Matsui Y, Hayakawa T, Tsuda N, Mogami H.
    No To Shinkei; 1986 Mar 15; 38(3):233-7. PubMed ID: 3486667
    [Abstract] [Full Text] [Related]

  • 32. Induction of natural killer effectors from human thymus with recombinant IL-2.
    Michon JM, Caligiuri MA, Hazanow SM, Levine H, Schlossman SF, Ritz J.
    J Immunol; 1988 May 15; 140(10):3660-7. PubMed ID: 3258886
    [Abstract] [Full Text] [Related]

  • 33. Alteration of human lymphokine-activated killer cell activity by manipulation of protein kinase C and cytosolic Ca2+.
    McCrady CW, Li F, Grant AJ, Merchant RE, Carchman RA.
    Cancer Res; 1988 Feb 01; 48(3):635-40. PubMed ID: 3257170
    [Abstract] [Full Text] [Related]

  • 34. Eradication of disseminated murine leukemia by treatment with high-dose interleukin 2.
    Thompson JA, Peace DJ, Klarnet JP, Kern DE, Greenberg PD, Cheever MA.
    J Immunol; 1986 Dec 01; 137(11):3675-80. PubMed ID: 3491145
    [Abstract] [Full Text] [Related]

  • 35. Anti-CD3 + IL-2-stimulated murine killer cells. In vitro generation and in vivo antitumor activity.
    Anderson PM, Blazar BR, Bach FH, Ochoa AC.
    J Immunol; 1989 Feb 15; 142(4):1383-94. PubMed ID: 2521662
    [Abstract] [Full Text] [Related]

  • 36. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
    Vujanovic NL, Herberman RB, Olszowy MW, Cramer DV, Salup RR, Reynolds CW, Hiserodt JC.
    Cancer Res; 1988 Feb 15; 48(4):884-90. PubMed ID: 3257412
    [Abstract] [Full Text] [Related]

  • 37. Obligatory role of IFN-gamma in induction of lymphokine-activated and T lymphocyte killer activity, but not in boosting of natural cytotoxicity.
    Giovarelli M, Santoni A, Jemma C, Musso T, Giuffrida AM, Cavallo G, Landolfo S, Forni G.
    J Immunol; 1988 Oct 15; 141(8):2831-6. PubMed ID: 3139768
    [Abstract] [Full Text] [Related]

  • 38. Effects of biological response modifiers on lung natural killer activity.
    Lauzon W, Lemaire I.
    Immunopharmacol Immunotoxicol; 1991 Oct 15; 13(3):237-50. PubMed ID: 1719060
    [Abstract] [Full Text] [Related]

  • 39. Human recombinant interleukin-2 augments porcine natural killer cell cytotoxicity in vivo.
    Hennessy KJ, Blecha F, Fenwick BW, Thaler RC, Nelssen JL.
    Ann Rech Vet; 1990 Oct 15; 21(2):101-9. PubMed ID: 2193595
    [Abstract] [Full Text] [Related]

  • 40. [Host immunological status modification by various chemotherapeutic drugs].
    Wakizaka Y, Yang ZB, Hosokawa M, Hata Y, Uchino J.
    Gan To Kagaku Ryoho; 1993 Aug 15; 20(11):1450-2. PubMed ID: 8373203
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.